CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Carl Zeiss Meditec AG - AFX CFD

85.89
6.54%
Market Trading Hours* (UTC) Opens on Thursday at 08:00

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.36
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022082 %
Charges from full value of position ($-4.20)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022082%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.00014 %
Charges from full value of position ($-0.03)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.00014%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5%
Stock exchange Germany
Commission on trade 0%

*Information provided by Capital.com

Carl Zeiss Meditec AG ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 80.62
Open* 81.53
1-Year Change* -36.86%
Day's Range* 81.53 - 86.23
52 wk Range 72.60-142.75
Average Volume (10 days) 98.62K
Average Volume (3 months) 2.59M
Market Cap 7.78B
P/E Ratio 25.33
Shares Outstanding 89.44M
Revenue 2.08B
EPS 3.43
Dividend (Yield %) 1.26437
Beta 0.70
Next Earnings Date Dec 12, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 6, 2023 85.89 4.06 4.96% 81.83 86.39 81.27
Dec 5, 2023 80.62 1.30 1.64% 79.32 81.09 78.22
Dec 4, 2023 82.25 -1.60 -1.91% 83.85 84.45 81.21
Dec 1, 2023 83.95 4.09 5.12% 79.86 84.41 79.32
Nov 30, 2023 82.53 -1.18 -1.41% 83.71 84.17 81.17
Nov 29, 2023 83.51 -1.46 -1.72% 84.97 85.85 83.33
Nov 28, 2023 85.25 -0.72 -0.84% 85.97 86.25 84.57
Nov 27, 2023 86.41 0.34 0.40% 86.07 87.31 86.07
Nov 24, 2023 86.55 0.52 0.60% 86.03 86.67 84.35
Nov 23, 2023 86.85 0.60 0.70% 86.25 86.97 85.95
Nov 22, 2023 86.67 1.14 1.33% 85.53 87.35 85.23
Nov 21, 2023 85.53 -0.44 -0.51% 85.97 86.53 84.91
Nov 20, 2023 86.01 -0.54 -0.62% 86.55 87.09 85.23
Nov 17, 2023 86.19 0.08 0.09% 86.11 87.40 85.95
Nov 16, 2023 86.37 0.68 0.79% 85.69 86.91 84.85
Nov 15, 2023 85.49 -1.28 -1.48% 86.77 88.48 85.23
Nov 14, 2023 86.89 5.74 7.07% 81.15 87.34 81.05
Nov 13, 2023 81.00 -3.55 -4.20% 84.55 84.97 80.12
Nov 10, 2023 84.65 0.60 0.71% 84.05 84.93 83.55
Nov 9, 2023 85.69 0.84 0.99% 84.85 85.91 84.53

Carl Zeiss Meditec AG Events

Time (UTC) Country Event
Tuesday, December 12, 2023

Time (UTC)

07:30

Country

DE

Event

Q4 2023 Carl Zeiss Meditec AG Earnings Release
Q4 2023 Carl Zeiss Meditec AG Earnings Release

Forecast

-

Previous

-

Time (UTC)

10:59

Country

DE

Event

Q4 2023 Carl Zeiss Meditec AG Earnings Call
Q4 2023 Carl Zeiss Meditec AG Earnings Call

Forecast

-

Previous

-
Thursday, February 8, 2024

Time (UTC)

07:30

Country

DE

Event

Q1 2024 Carl Zeiss Meditec AG Earnings Release
Q1 2024 Carl Zeiss Meditec AG Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 1902.84 1646.79 1335.45 1459.32 1280.86
Revenue 1902.84 1646.79 1335.45 1459.32 1280.86
Cost of Revenue, Total 775.238 679.572 589.935 627.437 570.471
Gross Profit 1127.6 967.213 745.517 831.884 710.389
Total Operating Expense 1505.96 1273.17 1157.9 1194.66 1083.73
Selling/General/Admin. Expenses, Total 438.06 363.98 349.161 393.913 353.646
Research & Development 291.365 232.066 218.804 173.312 159.628
Operating Income 396.879 373.614 177.552 264.659 197.13
Interest Income (Expense), Net Non-Operating -44.479 -32.12 -21.351 -34.497 -20.449
Other, Net 51.089 -2.444 22.516 -0.304 2.502
Net Income Before Taxes 403.489 339.05 178.717 229.858 179.183
Net Income After Taxes 295.911 237.519 123.421 160.579 126.23
Minority Interest -2.002 -1.243 -1.036 -0.823 0.233
Net Income Before Extra. Items 293.909 236.276 122.385 159.756 126.463
Net Income 293.909 236.276 122.385 159.756 126.463
Income Available to Common Excl. Extra. Items 293.909 236.276 122.385 159.756 126.463
Income Available to Common Incl. Extra. Items 293.909 236.276 122.385 159.756 126.463
Diluted Net Income 293.909 236.276 122.385 159.756 126.463
Diluted Weighted Average Shares 89.4406 89.4406 89.4406 89.4406 89.4406
Diluted EPS Excluding Extraordinary Items 3.28608 2.64171 1.36834 1.78617 1.41393
Dividends per Share - Common Stock Primary Issue 1.1 0.9 0.5 0.65 0.55
Diluted Normalized EPS 3.28608 2.62254 1.41621 1.826 1.44229
Unusual Expense (Income) -2.447 0
Other Operating Expenses, Total 1.294 0 -0.015
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 535.121 504.218 470.261 569.936 477.495
Revenue 535.121 504.218 470.261 569.936 477.495
Cost of Revenue, Total 219.147 212.047 212.906 227.538 193.645
Gross Profit 315.974 292.171 257.355 342.398 283.85
Total Operating Expense 434.102 420.599 409.999 448.957 378.919
Selling/General/Admin. Expenses, Total 124.469 124.304 116.127 133.26 111.092
Research & Development 90.386 84.248 80.966 87.165 73.972
Unusual Expense (Income)
Operating Income 101.019 83.619 60.262 120.979 98.576
Interest Income (Expense), Net Non-Operating 29.898 10.035 11.667 -2.679 -12.957
Other, Net 1.424 -2.943 1.119 22.689 2.71
Net Income Before Taxes 132.341 90.711 73.048 140.989 88.329
Net Income After Taxes 92.038 63.287 50.575 103.811 61.996
Minority Interest 0.113 -1.284 0.471 -1.102 0.536
Net Income Before Extra. Items 92.151 62.003 51.046 102.709 62.532
Net Income 92.151 62.003 51.046 102.709 62.532
Income Available to Common Excl. Extra. Items 92.151 62.003 51.046 102.709 62.532
Income Available to Common Incl. Extra. Items 92.151 62.003 51.046 102.709 62.532
Diluted Net Income 92.151 62.003 51.046 102.709 62.532
Diluted Weighted Average Shares 89.3781 89.8594 89.7904 89.7249 89.3318
Diluted EPS Excluding Extraordinary Items 1.03102 0.69 0.5685 1.14471 0.7
Dividends per Share - Common Stock Primary Issue 0 0 0 1.1 0
Diluted Normalized EPS 1.09327 0.69 0.5685 1.14471 0.7
Other Operating Expenses, Total 0.1 0 0 0.994 0.21
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 1791.85 1604.02 1290.51 1304.33 1251.06
Cash and Short Term Investments 7.729 7.439 6.202 22.639 7.843
Cash 7.729 7.439 6.202 22.639 6.678
Cash & Equivalents
Total Receivables, Net 1366.44 1294.65 979.93 1000.34 981.046
Accounts Receivable - Trade, Net 414.281 320.808 165.158 205.789 192.33
Total Inventory 382.745 286.375 286.36 268.322 248.092
Prepaid Expenses 14.245 9.502 8.144 10.759 9.352
Other Current Assets, Total 20.698 6.049 9.871 2.266 4.723
Total Assets 2822.82 2395.97 2014.85 2022.13 1662.05
Property/Plant/Equipment, Total - Net 236.145 199.555 135.265 116.752 62.632
Property/Plant/Equipment, Total - Gross 458.771 379.88 320.308 280.47 196.305
Accumulated Depreciation, Total -222.626 -180.325 -185.043 -163.718 -133.673
Goodwill, Net 429.648 328.714 326.51 338.094 185.638
Intangibles, Net 240.427 153.698 145.221 144.336 74.087
Long Term Investments 10.828 6.713 4.108 5.173 0.122
Note Receivable - Long Term 8.626 9.191 9.225 10.961 9.29
Other Long Term Assets, Total 105.29 94.079 104.014 102.484 79.227
Total Current Liabilities 539.316 448.118 297.584 339.6 280.18
Accounts Payable 189.185 145.465 91.679 118.12 101.437
Accrued Expenses 153.63 137.816 109.294 115.657 98.181
Notes Payable/Short Term Debt 0.098 0.645 0.209 0.192 15.71
Current Port. of LT Debt/Capital Leases 21.587 19.341 15.512 14.661 3.529
Other Current Liabilities, Total 174.816 144.851 80.89 90.97 61.323
Total Liabilities 807.717 736.641 583.133 623.69 368.588
Total Long Term Debt 198.088 178.425 140.636 151.837 7.321
Long Term Debt 91.772 76.496 87.543 109.009 0
Capital Lease Obligations 106.316 101.929 53.093 42.828 7.321
Deferred Income Tax 22.379 15.438 17.166 18.198 5.234
Minority Interest 14.991 18.056 18.841 18.517 21.17
Other Liabilities, Total 32.943 76.604 108.906 95.538 54.683
Total Equity 2015.1 1659.33 1431.72 1398.44 1293.46
Common Stock 89.441 89.441 89.441 89.441 89.441
Additional Paid-In Capital 620.137 620.137 620.137 620.137 620.137
Retained Earnings (Accumulated Deficit) 1213.89 1000.48 808.922 744.673 632.486
Other Equity, Total 91.632 -50.729 -86.783 -55.812 -48.6
Total Liabilities & Shareholders’ Equity 2822.82 2395.97 2014.85 2022.13 1662.05
Total Common Shares Outstanding 89.4406 89.4406 89.4406 89.4406 89.4406
Short Term Investments 0 1.165
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total Current Assets 1689.11 1791.85
Cash and Short Term Investments 44.327 32.914
Cash & Equivalents 12.364 7.729
Short Term Investments 31.963 25.185
Total Receivables, Net 1162.35 1326.46
Accounts Receivable - Trade, Net 387.753 414.281
Total Inventory 441.409 382.745
Other Current Assets, Total 41.02 49.734
Total Assets 2732.13 2822.82
Property/Plant/Equipment, Total - Net 283.03 236.145
Goodwill, Net 399.657 429.648
Intangibles, Net 232.068 240.427
Long Term Investments 22.417 10.828
Note Receivable - Long Term 12.178 8.626
Other Long Term Assets, Total 93.669 105.29
Total Current Liabilities 493.169 539.316
Accounts Payable 192.459 189.185
Accrued Expenses 113.317 141.979
Notes Payable/Short Term Debt 0 0
Current Port. of LT Debt/Capital Leases 22.22 21.587
Other Current Liabilities, Total 165.173 186.565
Total Liabilities 769.565 807.717
Total Long Term Debt 199.713 198.088
Long Term Debt 65.187 91.772
Capital Lease Obligations 134.526 106.316
Deferred Income Tax 21.468 22.379
Minority Interest 15.508 14.991
Other Liabilities, Total 39.707 32.943
Total Equity 1962.56 2015.1
Common Stock 89.441 89.441
Additional Paid-In Capital 620.137 620.137
Retained Earnings (Accumulated Deficit) 1228.55 1213.89
Other Equity, Total 24.429 91.632
Total Liabilities & Shareholders’ Equity 2732.13 2822.82
Total Common Shares Outstanding 89.4406 89.4406
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 295.911 237.519 123.421 160.579 126.23
Cash From Operating Activities 188.199 362.663 178.527 219.634 187.207
Cash From Operating Activities 69.769 61.584 60.425 48.37 31.282
Non-Cash Items 52.26 110.074 58.691 76.373 54.526
Cash Taxes Paid 120.444 97.908 58.964 65.07 48.364
Cash Interest Paid 1.52 1.629 1.365 1.903 1.94
Changes in Working Capital -229.741 -46.514 -64.01 -65.688 -24.831
Cash From Investing Activities -148.894 -75.2 -70.947 -145.846 -28.874
Capital Expenditures -81.971 -66.101 -44.986 -46.711 -34.756
Other Investing Cash Flow Items, Total -66.923 -9.099 -25.961 -99.135 5.882
Cash From Financing Activities -38.236 -285.889 -122.961 -58.637 -157.237
Financing Cash Flow Items 64.218 -223.862 -48.775 4.321 -104.529
Total Cash Dividends Paid -80.497 -44.72 -58.136 -49.192 -49.192
Issuance (Retirement) of Debt, Net -21.957 -17.307 -16.05 -13.766 -3.516
Foreign Exchange Effects -0.779 -0.337 -1.056 0.81 1.657
Net Change in Cash 0.29 1.237 -16.437 15.961 2.753
Issuance (Retirement) of Stock, Net 0
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 113.862 130.104
Cash From Operating Activities 47.798 74.484
Cash From Operating Activities 37.25 33.045
Non-Cash Items 52.096 16.671
Cash Taxes Paid 59.893 61.722
Cash Interest Paid 1.313 0.679
Changes in Working Capital -155.41 -105.336
Cash From Investing Activities -73.192 -54.311
Capital Expenditures -52.339 -35.335
Other Investing Cash Flow Items, Total -20.853 -18.976
Cash From Financing Activities 30.781 -18.33
Financing Cash Flow Items 140.271 -9.441
Issuance (Retirement) of Debt, Net -11.105 -8.889
Foreign Exchange Effects -0.752 -0.881
Net Change in Cash 4.635 0.962
Total Cash Dividends Paid -98.385
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Carl Zeiss Group Corporation 59.14 52895153 0 2023-10-24 LOW
Capital Research Global Investors Investment Advisor 2.9423 2631569 0 2023-10-24 LOW
Comgest S.A. Investment Advisor 1.6686 1492394 289432 2023-09-30 LOW
DWS Investment GmbH Investment Advisor/Hedge Fund 1.6391 1466038 -11904 2023-09-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.1903 1064644 2022 2023-09-30 LOW
Invesco Advisers, Inc. Investment Advisor 0.9902 885678 113570 2023-08-31 LOW
Allianz Global Investors GmbH Investment Advisor 0.8315 743673 2529 2023-09-30 LOW
BlackRock Asset Management Deutschland AG Investment Advisor 0.7289 651924 -2150 2023-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.7244 647912 -11863 2023-09-30 LOW
Candriam Luxembourg S.A. Investment Advisor 0.6658 595499 -18843 2023-09-30 MED
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.6096 545274 79036 2023-09-30 LOW
AllianceBernstein L.P. Investment Advisor/Hedge Fund 0.4223 377705 -14723 2023-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.4095 366292 -451602 2022-12-31 LOW
La Financière de l'Echiquier Investment Advisor 0.3822 341840 40619 2023-09-30 MED
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.3635 325128 1217 2023-09-30 LOW
Oddo BHF Asset Management S.A.S Investment Advisor/Hedge Fund 0.3107 277884 0 2023-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.255 228105 1 2023-09-30 LOW
Groupama Asset Management Investment Advisor 0.2483 222037 -136929 2023-09-30 LOW
Lupus alpha Asset Management AG Investment Advisor/Hedge Fund 0.2225 199000 34000 2023-06-30 MED
Rathbone Unit Trust Management Limited Investment Advisor/Hedge Fund 0.2161 193295 100074 2023-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Carl Zeiss Meditec Company profile

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.

Financial summary

BRIEF: For the three months ended 31 December 2021, Carl Zeiss Meditec AG revenues increased 11% to EUR410.2M. Net income decreased 18% to EUR37.9M. Revenues reflect Ophthalmic Devices segment increase of 10% to EUR310.9M, Microsurgery segment increase of 16% to EUR99.3M, Asia/Pacific Region segment increase of 15% to EUR181.5M, EMEA segment increase of 5% to EUR114.1M.

Equity composition

10/2006, Rights Issue, 3 new shares for every 2 shares held @ EUR 10.1 (Factor: 1.369066).

Industry: Advanced Medical Equipment & Technology (NEC)

Göschwitzer Straße 51-52
JENA
THUERINGEN 07745
DE

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

Oil - Crude

69.93 Price
-3.200% 1D Chg, %
Long position overnight fee -0.0207%
Short position overnight fee -0.0013%
Overnight fee time 22:00 (UTC)
Spread 0.040

XRP/USD

0.64 Price
+1.760% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Gold

2,027.11 Price
+0.510% 1D Chg, %
Long position overnight fee -0.0196%
Short position overnight fee 0.0114%
Overnight fee time 22:00 (UTC)
Spread 0.50

BTC/USD

43,984.60 Price
+0.100% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading